Department of Medical Chemistry, Semmelweis University, Budapest, Hungary.
Cell Death Differ. 2013 Dec;20(12):1654-63. doi: 10.1038/cdd.2013.129. Epub 2013 Oct 4.
Adipose tissue dysregulation has a major role in various human diseases. The peroxisome proliferator-activated receptor-γ (PPARγ) is a key regulator of adipocyte differentiation and function, as well as a target of insulin-sensitizing drugs. The Hsp90 chaperone stabilizes a diverse set of signaling 'client' proteins, thereby regulates various biological processes. Here we report a novel role for Hsp90 in controlling PPARγ stability and cellular differentiation. Specifically, we show that the Hsp90 inhibitors geldanamycin and novobiocin efficiently impede the differentiation of murine 3T3-L1 preadipocytes. Geldanamycin at higher concentrations also inhibits the survival of both developing and mature adipocytes, respectively. Further, Hsp90 inhibition disrupts an Hsp90-PPARγ complex, leads to the destabilization and proteasomal degradation of PPARγ, and inhibits the expression of PPARγ target genes, identifying PPARγ as an Hsp90 client. A similar destabilization of PPARγ and a halt of adipogenesis also occur in response to protein denaturing stresses caused by a single transient heat-shock or proteasome inhibition. Recovery from stress restores PPARγ stability and adipocyte differentiation. Thus, our findings reveal Hsp90 as a critical stress-responsive regulator of adipocyte biology and offer a potential therapeutic target in obesity and the metabolic syndrome.
脂肪组织失调在各种人类疾病中起着重要作用。过氧化物酶体增殖物激活受体-γ(PPARγ)是脂肪细胞分化和功能的关键调节剂,也是胰岛素增敏药物的靶点。热休克蛋白 90(Hsp90)伴侣稳定了一系列不同的信号“客户”蛋白,从而调节了各种生物学过程。在这里,我们报告了 Hsp90 控制 PPARγ 稳定性和细胞分化的新作用。具体来说,我们表明 Hsp90 抑制剂格尔德霉素和诺维本能够有效地抑制小鼠 3T3-L1 前脂肪细胞的分化。较高浓度的格尔德霉素还分别抑制了正在发育和成熟的脂肪细胞的存活。此外,Hsp90 抑制破坏了 Hsp90-PPARγ 复合物,导致 PPARγ 的不稳定和蛋白酶体降解,并抑制了 PPARγ 靶基因的表达,从而确定了 PPARγ 是 Hsp90 的客户。在响应单一短暂热休克或蛋白酶体抑制引起的蛋白质变性应激时,也会发生类似的 PPARγ 不稳定和脂肪生成停滞。从应激中恢复会恢复 PPARγ 的稳定性和脂肪细胞分化。因此,我们的发现揭示了 Hsp90 作为脂肪细胞生物学的关键应激反应调节剂,并为肥胖症和代谢综合征提供了一个潜在的治疗靶点。